NuSirt Sciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.nusirt.com
The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity
Phase 2
Completed
- Conditions
- Obesity
- Interventions
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 267
- Registration Number
- NCT03364335
- Locations
- 🇺🇸
Northern California Research, Sacramento, California, United States
🇺🇸ACR, Jordan, Utah, United States
🇺🇸Premier, Clarksville, Tennessee, United States
The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease
Phase 2
Completed
- Conditions
- NAFLD
- Interventions
- Drug: PlaceboDrug: Leu-Met-Sil 0.5Drug: Leu-Met-Sil 1.0
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2018-05-02
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 91
- Registration Number
- NCT02546609
- Locations
- 🇺🇸
Catalina Research Institute, Chino, California, United States
🇺🇸Atlanta Gastroenterology Associates, Atlanta, Georgia, United States
🇺🇸Rocky Mountain Research, Wheat Ridge, Colorado, United States
An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 50
- Registration Number
- NCT02435277
- Locations
- 🇺🇸
River Birch Research Alliance, Blue Ridge, Georgia, United States
🇺🇸Medical Research South, Charleston, South Carolina, United States
🇺🇸Catalina Research Institute, Chino, California, United States
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2018-02-27
- Lead Sponsor
- NuSirt Biopharma
- Target Recruit Count
- 96
- Registration Number
- NCT02151461
- Locations
- 🇺🇸
Meridian Research, Savannah, Georgia, United States
🇺🇸Meharry Medical College, Nashville, Tennessee, United States
🇺🇸Palm Beach Research, Palm Beach, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath